Literature DB >> 8548694

The influence of supplemental chromium and vaccines on the acute phase response of newly arrived feeder calves.

A J Wright1, B A Mallard, D N Mowat.   

Abstract

The acute phase response as indicated by serum haptoglobin and total haemolytic complement activity (CH50) was measured in 72 cross-bred steer calves purchased at sales in Ontario. During the 28 day (d) trial, 18 steers were randomly assigned to each of the following groups: 1) control; 2) vaccinated (Infectious Bovine Rhinotracheitis, Parainfluenza-3, Bovine Viral Diarrhea, Bovine Respiratory Synctial Virus vaccine plus Pasteurella haemolytica vaccine); 3) supplemental chelated Cr (0.14 mg/kg); and 4) Cr plus vaccines. Haptoglobin concentrations were low at arrival, increased (P < 0.05) on day 7, and returned to near initial levels (P > 0.05) by day 14. Supplemental Cr reduced (P < 0.05) haptoglobin on day 7 when morbidity was highest. Following antibiotic treatment for respiratory disease haptoglobin was lower (P < 0.05) than during morbidity; however, during morbidity, haptoglobin concentrations were not greater in sick calves (P > 0.05) than in healthy calves. Complement activity was lowest on day 7 (P < 0.05) and peaked on day 14 (P < 0.05). Complement activity tended to be lower on day 7 for vaccine, Cr, and Cr+ vaccine groups; however, the difference from controls was not significant (P > 0.10). Complement activity did not increase on day 14 (P > 0.05) with Cr supplementation as in other treatments. Morbid calves had lower (P < 0.05) CH50 activity than healthy calves on day 14. Following antibiotic treatment, the Cr-supplemented group had higher (P < 0.05) CH50 than during morbidity. In general, chromium supplementation reduced the acute phase response in newly arrived feeder calves.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8548694      PMCID: PMC1263787     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  13 in total

1.  Market stress-associated changes in serum complement activity in feeder calves.

Authors:  C W Purdy; A B Richards; G S Foster
Journal:  Am J Vet Res       Date:  1991-11       Impact factor: 1.156

2.  A new hemolytic assay for bovine serum complement and its application during experimental bovine anaplasmosis.

Authors:  A M Soler-Rodríguez; E Romano; Y Aranguren; A Soyano
Journal:  Vet Immunol Immunopathol       Date:  1990-04       Impact factor: 2.046

Review 3.  Bovine and canine acute phase proteins.

Authors:  P D Eckersall; J G Conner
Journal:  Vet Res Commun       Date:  1988       Impact factor: 2.459

4.  A simple method for the quantitative determination of serum haptoglobin.

Authors:  R B Roy; R W Shaw; G E Connell
Journal:  J Lab Clin Med       Date:  1969-10

5.  Serum complement activity of protein-energy malnourished beef cows.

Authors:  L F Woodward; W P Eckblad; D P Olson; R C Bull; D O Everson
Journal:  Am J Vet Res       Date:  1980-09       Impact factor: 1.156

6.  Acute phase response in calves following infection with Pasteurella haemolytica, Ostertagia ostertagi and endotoxin administration.

Authors:  J G Conner; P D Eckersall; A Wiseman; R K Bain; T A Douglas
Journal:  Res Vet Sci       Date:  1989-09       Impact factor: 2.534

7.  Supplemental chromium for stressed and growing feeder calves.

Authors:  X Chang; D N Mowat
Journal:  J Anim Sci       Date:  1992-02       Impact factor: 3.159

8.  Bovine haptoglobin response in clinically defined field conditions.

Authors:  J G Skinner; R A Brown; L Roberts
Journal:  Vet Rec       Date:  1991-02-16       Impact factor: 2.695

9.  Influence of major histocompatibility genes on serum hemolytic complement activity in miniature swine.

Authors:  B A Mallard; B N Wilkie; B W Kennedy
Journal:  Am J Vet Res       Date:  1989-03       Impact factor: 1.156

10.  Bovine acute phase response following turpentine injection.

Authors:  J G Conner; P D Eckersall; A Wiseman; T C Aitchison; T A Douglas
Journal:  Res Vet Sci       Date:  1988-01       Impact factor: 2.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.